CDK12 plays an important role in the growth of cancers driven by dysregulated transcription factors, such as MYC (neuroblastoma) [13] and the EWS–FLI1 fusion (Ewing sarcoma) [14], or in melanoma driven by activating mutations in BRAF [15]. This evidence concerns the gene BRAF and melanoma.